Twist Bioscience Oligo Pools are being leveraged in a variety of exciting new applications aimed at expanding our understanding of biology.
On April 21st, we’re hosting Dr. Tilmann Buerckstuemmer, CSO of Aelian Biotechnology, who’ll be talking to us about leveraging two transformative technologies - CRISPR screening and single cell transcriptomics - to enable genetic screening for complex phenotypes.
During this webinar Dr. Buerckstuemmer will discuss:
- how Aelian Biotechnology is using CROP-seq to expand beyond more simplistic screening read-outs.
- how this screening approach can be used to map known signalling pathways and assess the impact of candidate regulators on transcriptional outcomes.
- the feasibility of using both unbiased and targeted single-cell RNA sequencing and how to compare these approaches side-by-side.
- the importance of Oligo Pool uniformity to ensure screening success and how the quality of Twist Oligo Pools uniquely enables these types of studies.